PROVIDER PROFILE · NPI 1053445155

Mae GutierrezM.D.

Family PracticeKey Biscayne, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,190

Unique beneficiaries

—

Total services

2,453

Distinct HCPCS

Medicare payment

$97K

Peer benchmark

Total Medicare services vs. 4,914 Family Practice providers in FL — top quintile (cohort median 682).

PRESCRIBING · PART D · 2024

Total Rx claims

2,812

Beneficiaries

—

Total drug cost

$341K

Distinct drugs

Brand share

8.3%

Top prescribed drugs

Ketoconazole549 claims

Triamcinolone Acetonide373 claims

Ammonium Lactate359 claims

Mometasone Furoate207 claims

Nystatin181 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

Education$8

REFERRAL NETWORK

Where Mae Gutierrez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 6 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	16	32

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Susana Leal-Khouri Dermatology · Key Biscayne, FL	68	118
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Miramar, FL	41	101
MARINERS HOSPITAL, INC	17	36
Kathryn Zeoli Dermatology · Pembroke Pines, FL	14	25
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	13	27
KHOURI LABORATORIES, INC	13	29

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history